NeoDynamics AB (publ) is a Swedish Medical Technology Company dedicated to advancing diagnosis and care of breast cancer. The company has an innovative biopsy system, NeoNavia, with CE approval in EU. The precision biopsy system is built on a patented pulse technology, based on research at the Karolinska Institutet in Sweden. The system is designed to offer clinicians and patients accurate lesion targeting and high tissue yield for correct diagnosis and individualized treatment. NeoNavia is evaluated at leading clinics in UK, Germany and Sweden. A commercial launch is initiated quarter IV, 2020. Expected to enter US in 2021.
Ticker:
NeoD
Exchange:
1 USD = 9 SEK
Company Type:
Publicly Traded Company
Company Website:
Company HQ State:
Not Provided
Company HQ Country:
Sweden
Year Founded:
2012
Main Therapeutic Focus:
Oncology
Lead Product in Development:
NeoNavia Biopsy system
Development Phase of Primary Product:
NDA Preparation / In Review
Number Of Unlicensed Products (For Which You Are Seeking Partners):
one biopsy system comprising 5 products
Speaker
